In vitro activities of M-4365 G2, a new basic 16-membered macrolide antibiotic, against a total 19 strains including human, bovine, porcine, rodent, avian and saprophytic mycoplasmas were compared with those of three other macrolide antibiotics, josamycin, erythromycin and tylosin. M-4365 G2 exhibited stronger activities than the other macrolide antibiotics against 11 strains of mycoplasma tested. Especially, its higher activities against M. pneumoniae Mac and FH, U. urealyticum T-960, M. mycoides PG-1 and M. gallisepticum Kp-13, PG-31 and 9-49A were to be noticed (final minimum inhibitory concentrations: 0.0001 ~0.049 μg/ml). Higher antimycoplasmal activity of M-4365 G2 than that of tylosin was also proved in experimental treatment of chickens intranasally inoculated with M. gallisepticum Kp-13 by feeding a diet containing the drug. M. gallisepticum Kp-13 was not isolated from the infected chickens fed a diet containing 0.0063 % or more of M-4365 G2. © 1981, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.
CITATION STYLE
Onta, T., Maezawa, I., Kinumaki, A., Ohshima, S., & Yamaguchi, T. (1981). macrolide antibiotics M-4365 produced by micromonospora IV. antimycoplasmal activity of antibiotic M-4365 G2(de-epoxy rosamicin)∂. Journal of Antibiotics, 34(6), 719–726. https://doi.org/10.7164/antibiotics.34.719
Mendeley helps you to discover research relevant for your work.